Correction: Fatal adverse events associated with programmed cell death ligand 1 inhibitors: a systematic review and meta-analysis

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-02-17
DOI
https://doi.org/10.3389/fphar.2026.1782058
Primary Topic
Cell death mechanisms and regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Fatal adverse events associated with programmed cell death ligand 1 inhibitors: a systematic review and meta-analysis

Y. Chen, Tingting Zhuang, Erqian Shao, Xiong Chen et al.
Frontiers in Pharmacology
Cell death mechanisms and regulation
article

Correction: Fatal adverse events associated with programmed cell death ligand 1 inhibitors: a systematic review and meta-analysis

Y. Chen, Tingting Zhuang, Erqian Shao, Xiong Chen, Linbin Lu, Xuewen Wang, Shijie Wu
article en

Abstract

No abstract available for this paper.
Frontiers in PharmacologyVol. 17
Fujian Medical University (CN)
Openalex Percentile: Top 52%
Cell death mechanisms and regulation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction: Fatal adverse events associated with programmed cell death ligand 1 inhibitors: a systematic review and meta-analysis — Y. Chen, Tingting Zhuang, et al. · Frontiers in Pharmacology (2026) | TGRS Research Map | TGRS